Patients with type 1 diabetes mellitus (T1DM) and end-stage kidney disease (ESKD) Nutritional, Metabolic, Endocrine
Conditions
Interventions
This study was approved by the University of Miami Institutional Review Board and follows the ethical principles (as revised in 2013) of the Helsinki Declaration. All patients gave written informed co
these 4 patients fulfilled the criteria set by the United Network for Organ Sharing. SPK recipients that were included in this study received a robotic-assisted SPK transplant (RASPKT).
Robotic-assi
Sponsors
Miami Transplant Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who gave written informed consent prior to enrollment 2. Patients placed on the SPK transplant list after an extensive evaluation reviewed by the multidisciplinary team 3. Fulfilled the criteria set by the United Network for Organ Sharing
Exclusion criteria
Exclusion criteria: SPK recipients at the participating center who received an open SPK (non-robotic assisted) transplant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Any surgical complications post-transplant, kidney and pancreas allograft function at 3-12 months post-transplant measured using data collected retrospectively from patient medical records at one timepoint | — |
Secondary
| Measure | Time frame |
|---|---|
| Operative time (min) and length of hospital stay (LOS) (days) measured using data collected retrospectively from patient medical records at one timepoint | — |
Countries
United States of America
Contacts
Public ContactGaetano Ciancio
Outcome results
None listed